Block 3 Lecture 3 -- Parkinson's Flashcards

1
Q

What proteins are misfolded in Parkinsons?

A

alpha-synuclein,
parkin

in the basal ganglia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the physiological signs of Parkinsons?

A

1) alpha-synuclein dysregulation – cortical and nigral Lewy Bodies
2) depigmentation of pars compacta in SN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the prevalence of PD.

A

2nd most common neurodegenerative disease

    • prevalence increases with age
    • mean age = 57
    • twice as common in males
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are environmental risk factors of PD?

A

neurotoxins
pesticides during development
TBI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the genetic/idiopathic breakdown of PD?

A

90 percent idiopathic

10 percent genetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the actions of MPP+?

A

1) free radicle introduction into vesicles after DAT uptake
- - increased cytoplasmic catecholamines – ROS – DA neuron death
2) inhibit Complex I in ETC
- - ROS, death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What PD symptoms start 5-10 years before diagnosis?

A

1) hyposmia
2) constipation
3) REM-sleep behavior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are motor sxs of PD?

A

1) resting tremor
2) cogwheel rigidity
3) bradykinesia
4) postural instability
5) reduced arm swinging, forward tilt, head trembling
6) small handwriting
7) potentially diagnostic
- - hypophonia, dysarthria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are ANS and sensory sxs of PD?

A

1) fatigue
2) anosmia
3) hyperalgesia/paresthesia
4) seborrhea
5) sexual dysfunction
6) mixed SNS/PNS effects
- - sialorrhea, diaphoresis, orthostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are CNS sxs of PD?

A

1) late-onset cognitive impairment in frontal cortex and subcortical regions
- - visuospatial, executive fx
2) depression
3) anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are goals of PD pharmacotherapy?

A

1) preserve fx and independence
2) improve mobility
3) improve non-motor sxs
4) delay progression (no drugs for this yet)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is nonpharm tx for PD?

A

1) subthalamic nucleus deep brain stimulation
2) surgery
- - pallidotomy, thalamotomy, subthalamotomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the MoA of amantadine?

A

1) enhances presynaptic DA release
2) DAT blocker
3) anti-cholinergic properties
4) NMDAr antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the MoA of benztropine?

A

M1r antagonist

    • b/c DA inhibits ACh release in striatum (ACh = tremor)
    • adjunct therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the ergot-based D2r agonists?

A

1) bromocriptine
2) cabergoline
3) pergolide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the non-ergot-based D2r agonists?

A

1) pramipexole

2) ropinirole

17
Q

What are the ADRs of non-ergot D2r agonists?

A

1) nausea
2) edema
3) orthostasis
4) sedation
5) confusion, vivid dreams, hallucination
6) risky behavior (gambling)

NO CERS (no cares)

18
Q

What are the direct-acting DAr agonists?

A

1) non-ergot D2r agonists

2) ergot D2r agonists

19
Q

What M1r antagonists are used in PD?

A

1) benztropine

2) trihyexyphenidyl

20
Q

What are the ADRs of DA replacement?

A

1) nausea
2) hallucination, dreams
3) insomnia
4) syncope

21
Q

What are the COMT inhibitors?

A

entacapone

tolcapone

22
Q

What are the MAOB inhibitors?

A

selegiline

rasagiline

23
Q

What is in stalevo?

A

L-dopa
carbidopa
entacapone

24
Q

What’s in Sinemet?

A

L-dopa + carbidopa

25/100mg TID

25
What are the goals of physical/speech therapy in PD?
1) regular exercise to maintain mobility, improve strength 2) avoid falls 3) late-stage swallowing therapy
26
What are symptoms of dyskinesias?
1) faciolingual tics 2) choreiform 3) oscillatory rocking
27
What are the shortcomings of DA replacement therapy?
1) tolerance to movement improvements 2) free radicals 3) peak-effect dyskinesias
28
What is the advantage of pramipexole?
less risk of motor complications as monotherapy | -- preferred in younger patients
29
What are the bad parts of ergot-based D2r agonist use?
1) more severe ADRs than non-ergot | 2) special monitoring required for cardiac valvular fibrosis
30
Where are ergot-based D2r agonists derived from?
fungus Claviceps purpurea
31
What patients suffer from peak-effect dyskinesias?
too much Da - - 50% of patients in year 5 - - more likely in younger patients
32
When is L-dopa therapy preferred?
cognitive problems/hallucination present | older patients
33
Does DA cross BBB? What about L-dopa?
0% DA; 5% L-dopa
34
When is amantadine preferred?
new patients with mild symptoms